GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)

Similar documents
Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Recent Updates on European Requirements and what QPs are expected to do

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Clinical Trial Logistics

Guideline on good pharmacovigilance practices (GVP)

COMMISSION IMPLEMENTING DECISION. of XXX. (Text with EEA relevance)

COMMISSION DIRECTIVE 2003/94/EC

Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle

EDQM Certificates of Suitability: Cooperation Among Inspectorates in Europe And Beyond

End of consultation (deadline for comments) 14 October Adoption by Committee for advanced therapies 15 October 2010

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

Guideline on good pharmacovigilance practices (GVP)

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group

Compilation of Community Procedures on Inspections and Exchange of Information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL VERSION 4.1

Author General Management Quality Assurance

PHARMACEUTICAL QUALITY SYSTEM Q10

EudraLex. The Rules Governing Medicinal Products in the European Union Volume 4

Auditing as a Component of a Pharmaceutical Quality System

Work plan for GMP/GDP Inspectors Working Group for 2016

Compilation of Community Procedures on Inspections and Exchange of Information

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY VERSION 7

Emerging Device Topics for Regulatory Consideration.. Janine Jamieson May 2015

Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors

Manual for ITC's clients, Conformity assessment of ACTIVE IMPLANTABLE MEDICAL DEVICES pursuant to Council Directive 90/385/EEC

REGULATION (EEC) No 2309/93

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1

Competentes en Medicamentos

New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01)

Presented by Rosemarie Bell 24 April 2014

NEW AND GLOBAL + OLD APPROACH PRODUCT LEGISLATION: A. Standard questionnaire to be filled for each sector individually:

Procedure for EFISC, operators and CB s

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

UNICEF s Quality Assurance System for procurement of medicines

Annex 7 Guidelines on pre-approval inspections

Audit of the control body through the monitoring of compliance with control plan. Measures for the irregularities

Guidance for Industry. Q10 Pharmaceutical Quality System

Quality Thinking in other Industries. Dominic Parry Inspired Pharma Training. WEB GMP BLOG inspiredpharmablog.

GMP Advisor The GMP Questions & Answers Guide Version 01 of April 2014

Manufacturing Cellular Products for International Clinical Trials

NABL accreditation is a formal recognition of the technical competence of a medical testing laboratory

1. Consultation of the Committee (SCFCAH)

APEC Preliminary Workshop: Review of Drug

ICH guideline Q10 on pharmaceutical quality system

Combination Products. Presented by: Karen S. Ginsbury For: IFF March PCI Pharma

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

Extemporaneously Prepared Early Phase Clinical Trial Materials

Community Guide to Good Practice For Feed Additive and Premixture Operators

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP)

Data Governance Planning PDA 12 May 2015

VOLUME 2A Procedures for marketing authorisation CHAPTER 1 MARKETING AUTHORISATION. November 2005

Comparison of FDA s Part 11 and the EU s Annex 11

REQUIREMENTS FOR NATIONAL AND MUTUAL RECOGNITIONS VMP APPLICATIONS

Annex 9 Guide to good storage practices for pharmaceuticals 1

TRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015

EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL. Brussels, ENTR/F2/BL D(2003) CT 1 Revision 2

Overview of Key Obligations Under Regulation (EC) No. 1272/2008 on the Classification, Labelling and Packaging of Substances and Mixtures (CLP)

Adoption by GCP Inspectors Working Group for consultation 14 June End of consultation (deadline for comments) 15 February 2012

Update: Proposed Medical Device Regulation (MDR) & IVD Regulation (IVDR)

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS (CVMP)

Having regard to the Treaty establishing the European Community, and in particular Article 95(1) thereof,

Importing pharmaceutical products to China

Guide to Good Distribution Practice of Medicinal Products for Human Use

RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING

Reflection paper on the Use of Interactive Response Technologies (Interactive Voice/Web Response Systems) in Clinical Trials

How companies leverage quality and quality certifications to achieve competitive advantage

The Quality System for Drugs in Germany

1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System

Annex 4 Good Manufacturing Practices for pharmaceutical products: main principles

ICH Q10 Pharmaceutical Quality System (PQS)

GMP Training Course Quality Control October Lesley Graham Senior Inspector (UK)

Conformity assessment certification

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

ANNEX F. Organic agriculture (Art. 11) ARTICLE 1. Objectives

European Regulatory Newsletter July - September 2013

Biotech Concerto #3. European Clinical Trial Environment

Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials

Allgemeine Rahmenbedingungen für die Entwicklung und Zulassung von Orphan Medicinal Products

QUALITY SYSTEM REQUIREMENTS FOR PHARMACEUTICAL INSPECTORATES

Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry

European Commission Contract no. FIF : Users Guide to European Regulation in Biotechnology. Final Report, Part I: Complete text

GMP Pharma BV. Netherlands

Guideline on dossier requirements for Type IA and IB notifications

GCP INSPECTORS WORKING GROUP <DRAFT> REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS

European Code of Conduct on Data Centre Energy Efficiency

Waste Electrical and Electronic Equipment. Information Document

Guidance for Industry: Starting Material Supplier Management

WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme

VOLUME 6A Procedures for marketing authorisation

Staying Current in Cold Chain Management

SADC GUIDELINES ON IMPORT AND EXPORT PROCEDURES FOR PHARMACEUTICAL PRODUCTS

Transcription:

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP) Presented by: Patrick Costello Scientific Administrator, European Medicines Agency An agency of the European Union

Introduction EU GMPs what and why? What does it mean for a start up Supply chain management Investigational Medicinal Products & Clinical trials Qualified Person 1 GMP Issues for Start Ups

GMP-what its not? Great Mounds of Paper 2 GMP Issues for Start Ups

GMP what it is? GMP shall mean the part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use 3 GMP Issues for Start Ups

GMP- what is it Article 40 -Member States shall take all appropriate measures to ensure that the manufacture of the medicinal products within their territory is subject to the holding of an authorization. This manufacturing authorization shall be required nothwithstanding that the medicinal products manufactured are intended for export Article 44- Member States shall take all appropriate measures to ensure that the manufacture of veterinary medicinal products in their territory is subject to the holding of an authorization. This manufacturing authorization shall likewise be required for veterinary medicinal products intended for export. 4 GMP Issues for Start Ups

GMP what is it? The rules governing medicinal products in the European Union contains guidance for the interpretation of the principles and guidelines of good manufacturing practices for medicinal products for human and veterinary use laid down in Commission Directive 2003/94/EC, and 91/412/EEC respectively. 5 GMP Issues for Start Ups

GMP what is it? Good Manufacturing Practice Part I Part II Part III Annexes Basic Requirements for Medicinal Products Basic Requirements for Active Substances used as Starting Materials GMP related documents Substance specific documents 9 Chapters 1 Chapter(49pg) 5 documents 19 annexes http://ec.europa.eu/health/documents/eudralex/vol-4/index_en.htm 6 GMP Issues for Start Ups

GMP for SME Quality System Premises / Equipment / Materials i. Facility designed a. Process flows for staff, equipment, materials & reagent, product, waste etc; b. Air quality, pressure differential defined, air flows c. Fit for purpose Pharma Large / Small University Based Hospital Based 7 GMP Issues for Start Ups

GMP for SME Quality System Premises / Equipment / Materials ii. Reagents / Materials a. Fit for purpose b. validation / qualification c. Quality of reagents No Laboratory / Reagent grade d. Batch acceptance of reagents 8 GMP Issues for Start Ups

GMP for SME Quality System -Documentation a. Need to have process defined b. Need to have procedures defined c. Appropriate forms / means for recording data to demonstrate consistency with defined process / procedures d. Control of the above 9 GMP Issues for Start Ups

GMP for SME Quality System - Personnel a. Adequate number of staff b. Some staff defined a. Head of Production b. Head of Quality Assurance c. Qualified Person c. Adequately trained staff d. Staff retention / loss of knowledge 10 GMP Issues for Start Ups

GMP for SME Quality System Key Components i. Management of change ii. Management of deviations / non conformances iii. Management of complaints 11 GMP Issues for Start Ups

Supply Chain Management Contracts detailed guidance in chapter 7 Supplier approval - audits? Testing of deliveries batch acceptance Resilience of the supply approve a number of suppliers for critical materials Risk assess the supply chain Assess impact of a change on product / comparability 12 GMP Issues for Start Ups

Investigational Medicinal Products and Clinical Trials Key legislative references Dedicate Annex in the guidelines Annex 13 Manufacture according to GMP Release of batches by QP batch certification defined http://ec.europa.eu/health/files/eudralex/vol-4/2009_06_annex13.pdf EMA Clinical Trials information http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/gener al/general_content_000489.jsp&mid=wc0b01ac058060676f http://ec.europa.eu/health/human-use/clinical-trials/index_en.htm 13 GMP Issues for Start Ups

The Qualified Person Legislative reference is article 48 of Directive 2001/83/EC with responsibilities defined in article 51 Guideline is Annex 16 (new draft in the progress) Batch testing and release of products manufactured in EC/EEA; Batch testing and release of products imported from a third country; Release of products imported from a third country (MRA partner); Routine Duties of the QP section 8 14 GMP Issues for Start Ups

Take Home Guidelines are available Can we interpret Specialist knowledge required QP Early contact essential Transition from lab to putting a product into a human / animal 15 GMP Issues for Start Ups

Take Home Advice (medicinal product Competent authority) Contact should be on-going Takes time from application to award of a manufacturing/ importation authorisation 16 GMP Issues for Start Ups

Thank you for your attention! 17 GMP Issues for Start Ups